Citi downgrades Emerson (NYSE: EMR) from Buy to Hold.

Citi analyst says, "EMR has also been an outperformer since ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE